|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hundahl SA, Phillips JL and Menck HR: The
national cancer data base report on poor survival of US gastric
carcinoma patients treated with gastrectomy: Fifth edition American
joint committee on cancer staging, proximal disease and the
‘different disease’ hypothesis. Cancer. 88:921–932. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yeh JM, Hur C, Schrag D, Kuntz KM, Ezzati
M, Stout N, Ward Z and Goldie SJ: Contribution of H. pylori and
smoking trends to US incidence of intestinal-type noncardia gastric
adenocarcinoma: A microsimulation model. PLoS Med. 10:e10014512013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laurén P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
5
|
Strieter RM, Belperio JA, Phillis RJ and
Keane MP: CXC chemokines in angiogenesis of cancer. Semin Cancer
Biol. 14:195–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moser B, Wolf M, Walz A and Loetscher P:
Chemokines: Multiple levels of leukocyte migration control. Trends
Immunol. 25:75–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rubie C, Frick VO, Wagner M, Rau B, Weber
C, Kruse B, Kempf K, Tilton B, König J and Schilling M: Enhanced
expression and clinical significance of CC-chemokine MIP-3 alpha in
hepatocellular carcinoma. Scand J Immunol. 63:468–477. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rubie C, Frick VO, Ghadjar P, Wagner M,
Grimm H, Vicinus B, Justinger C, Graeber S and Schilling MK:
CCL20/CCR6 expression profile in pancreatic cancer. J Transl Med.
8:45–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rubie C, Oliveira V, Kempf K, Wagner M,
Tilton B, Rau B, Kruse B, Konig J and Schilling M: Involvement of
chemokine receptor CCR6 in colorectal cancer metastasis. Tumour
Biol. 27:166–174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rossi D and Zlotnik A: The biology of
chemokines and their receptors. Annu Rev Immunol. 18:217–242. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hattermann K and Mentlein R: An infernal
trio: The chemokine CXCL12 and its receptors CXCR4 and CXCR7 in
tumor biology. Ann Anat. 195:103–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esencay M, Sarfraz Y and Zagzag D: CXCR7
is induced by hypoxia and mediates glioma cell migration towards
SDF-1α. BMC Cancer. 13:347–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McIver SC, Loveland KL, Roman SD, Nixon B,
Kitazawa R and McLaughlin EA: The chemokine CXCL12 and its receptor
CXCR4 are implicated in human seminoma metastasis. Andrology.
1:517–529. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao YX, Zhou CH, Zeng H, Zuo DQ, Wang ZY,
Yin F, Hua YQ and Cai ZD: The role of the CXCL12-CXCR4/CXCR7 axis
in the progression and metastasis of bone sarcomas. Int J Mol Med.
32:1239–1246. 2013.PubMed/NCBI
|
|
15
|
Singh S, Malik BK and Sharma DK: Targeting
HIV-1 through molecular modeling and docking studies of CXCR4:
Leads for therapeutic development. Chem Biol Drug Des. 69:191–203.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hwang TL, Lee LY, Wang CC, Liang Y, Huang
SF and Wu CM: CCL7 and CCL21: Overexpression in gastric cancer is
associated with lymph node metastasis and poor prognosis. World J
Gastroenterol. 18:1249–1256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ying J, Xu Q, Zhang G, Liu B and Zhu L:
The expression of CXCL12 and CXCR4 in gastric cancer and their
correlation to lymph node metastasis. Med Oncol. 29:1716–1722.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sobin LH: TNM, sixth edition. New
developments in general concepts and rules. Semin Surg Oncol.
21:19–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bustin SA: Absolute quantification of mRNA
using real time reverse transcription polymerase chain reaction
assays. J Mol Endocrinol. 25:169–193. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rubie C, Kempf K, Hans J, Su T, Tilton B,
Georg T, Brittner B, Ludwig B and Schilling M: Housekeeping gene
variability in normal and cancerous colorectal, pancreatic,
esophageal, gastric and hepatic tissues. Mol Cell Probes.
19:101–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schoonjans F, Zalata A, Depuydt CE and
Comhaire FH: MedCalc: A new computer program for medical
statistics. Comput Methods Programs Biomed. 48:257–262. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lombardi L, Tavano F, Morelli F, Latiano
TP, Di Sebastiano P and Maiello E: Chemokine receptor CXCR4: Role
in gastrointestinal cancer. Crit Rev Oncol Hematol. 88:696–705.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meads MB, Hazlehurst LA and Dalton WS: The
bone marrow microenvironment as a tumour sanctuary and contributor
to drug resistance. Clin Cancer Res. 14:2519–2526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smith MC, Luker KE, Garbow JR, Prior JL,
Jackson E, Piwnica-Worms D and Luker GD: CXCR4 regulates growth of
both primary and metastatic breast cancer. Cancer Res.
64:8604–8612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan J, Mestas J, Burdick MD, Phillips RJ,
Thomas GV, Reckamp K, Belperio JA and Strieter RM: Stromal derived
factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma
metastasis. Mol Cancer. 5:56–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taichman RS, Cooper C, Keller ET, Pienta
KJ, Taichman NS and McCauley LK: Use of the stromal cell-derived
factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Cancer Res. 62:1832–1837. 2002.PubMed/NCBI
|
|
27
|
Schimanski CC, Bahre R, Gockel I, Müller
A, Frerichs K, Hörner V, Teufel A, Simiantonaki N, Biesterfeld S
and Wehler T: Dissemination of hepatocellular carcinoma is mediated
via chemokine receptor CXCR4. Brit J Cancer. 95:210–217. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mori T, Doi R, Koizumi M, Toyoda E, Ito D,
Kami K, Masui T, Fujimoto K, Tamamura H and Hiramatsu K: CXCR4
antagonist inhibits stromal cell-derived factor 1-induced migration
and invasion of human pancreatic cancer. Mol Cancer Ther. 3:29–37.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zeelenberg IS, Ruuls-Van Stalle L and Roos
E: The chemokine receptor CXCR4 is required for outgrowth of colon
carcinoma micrometastases. Cancer Res. 63:3833–3839.
2003.PubMed/NCBI
|
|
30
|
Kim J, Takeuchi H, Lam ST, Turner RR, Wang
HJ, Kuo C, Foshag L, Bilchik AJ and Hoon DS: Chemokine receptor
CXCR4 expression in colorectal cancer patients increases the risk
for recurrence and for poor survival. J Clin Oncol. 23:2744–2753.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saigusa S, Toiyama Y, Tanaka K, Yokoe T,
Okugawa Y, Kawamoto A, Yasuda H, Inoue Y, Miki C and Kusunoki M:
Stromal CXCR4 and CXCL12 expression is associated with distant
recurrence and poor prognosis in rectal cancer after
chemoradiotherapy. Ann Surg Oncol. 17:2051–2058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oliveira Frick V, Rubie C, Ghadjar P,
Faust SK, Wagner M, Gräber S and Schilling MK: Changes in
CXCL12/CXCR4-chemokine expression during onset of colorectal
malignancies. Tumour Biol. 32:189–196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rubie C, Frick VO, Ghadjar P, Wagner M,
Justinger C, Faust SK, Vicinus B, Gräber S, Kollmar O and Schilling
MK: CXC receptor-4 mRNA silencing abrogates CXCL12-induced
migration of colorectal cancer cells. J Transl Med. 9:222011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arigami T, Natsugoe S, Uenosono Y,
Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and
CXCR4 expression predicts lymph node status including
micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yasumoto K, Koizumi K, Kawashima A, Saitoh
Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H and
Takahashi Y: Role of the CXCL12/CXCR4 axis in peritoneal
carcinomatosis of gastric cancer. Cancer Res. 66:2181–2187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
